DE69116606D1 - Bacterin zur Behandlung von Necrophorum-Krankheiten und Verfahren zur Herstellung - Google Patents

Bacterin zur Behandlung von Necrophorum-Krankheiten und Verfahren zur Herstellung

Info

Publication number
DE69116606D1
DE69116606D1 DE69116606T DE69116606T DE69116606D1 DE 69116606 D1 DE69116606 D1 DE 69116606D1 DE 69116606 T DE69116606 T DE 69116606T DE 69116606 T DE69116606 T DE 69116606T DE 69116606 D1 DE69116606 D1 DE 69116606D1
Authority
DE
Germany
Prior art keywords
necrophorum
bacterin
diseases
manufacture
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69116606T
Other languages
English (en)
Other versions
DE69116606T2 (de
Inventor
John N Berg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Bayer Corp
Original Assignee
Bayer AG
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG, Bayer Corp filed Critical Bayer AG
Publication of DE69116606D1 publication Critical patent/DE69116606D1/de
Application granted granted Critical
Publication of DE69116606T2 publication Critical patent/DE69116606T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/114—Fusobacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69116606T 1990-06-07 1991-05-25 Bacterin zur Behandlung von Necrophorum-Krankheiten und Verfahren zur Herstellung Expired - Fee Related DE69116606T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53489490A 1990-06-07 1990-06-07

Publications (2)

Publication Number Publication Date
DE69116606D1 true DE69116606D1 (de) 1996-03-07
DE69116606T2 DE69116606T2 (de) 1996-05-30

Family

ID=24131961

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69116606T Expired - Fee Related DE69116606T2 (de) 1990-06-07 1991-05-25 Bacterin zur Behandlung von Necrophorum-Krankheiten und Verfahren zur Herstellung
DE69133172T Expired - Fee Related DE69133172T2 (de) 1990-06-07 1991-05-25 Bacterin zur Behandlung von Lebernekrose verursacht durch F. Necrophorum

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69133172T Expired - Fee Related DE69133172T2 (de) 1990-06-07 1991-05-25 Bacterin zur Behandlung von Lebernekrose verursacht durch F. Necrophorum

Country Status (8)

Country Link
US (1) US6132709A (de)
EP (2) EP0460480B1 (de)
AU (1) AU644440B2 (de)
CA (1) CA2043932C (de)
DE (2) DE69116606T2 (de)
ES (2) ES2084057T3 (de)
IE (1) IE72181B1 (de)
NZ (1) NZ238378A (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455034A (en) * 1992-06-26 1995-10-03 Kansas State University Research Foundation Fusobacterium necrophorum leukotoxoid vaccine
AU675234B2 (en) * 1992-06-26 1997-01-30 Kansas State University Research Foundation Fusobacterium necrophorum leukotoxoid vaccine
ATE506074T1 (de) * 1995-06-07 2011-05-15 Univ Kansas State Actinomyces pyogenes und actinomyces pyogenes/fusobakterium necrophorum impfstoffe zur immunisierung von vieh und schafen
US5861162A (en) * 1995-06-07 1999-01-19 Kansas State University Research Foundation Multivalent inocula for lessening incidence of liver abscesses in cattle
US6632439B2 (en) * 1999-09-29 2003-10-14 Novartis Animal Health, Inc. Fusobacterium necrophorum vaccine and method for making such vaccine
US6548069B2 (en) 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin
WO2009090093A1 (en) 2008-01-18 2009-07-23 Werner Lubitz Bacterial ghost (bg) production process using betapropiolactone (blp) for final inactivation
US9827299B2 (en) 2009-10-09 2017-11-28 Children's Medical Center Corporation Selectively disrupted whole-cell vaccine
MX370397B (es) 2012-11-29 2019-12-11 Univ Cornell Vacuna para enfermedad intrauterina.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA984293A (en) * 1971-08-20 1976-02-24 Richard W. Moore Medium and method for growth of superiorly antigenic equine infectious anemia virus and production of immunizing vaccine therefrom
FR2174745A1 (en) * 1972-03-09 1973-10-19 Inst Elevage Med Vet Mixed veterinary vaccine - active against symptomatic and bacterial anthrax
US4061751A (en) * 1976-07-22 1977-12-06 American Cyanamid Company 6-Substituted 3-nitroimidazo[1,2-b]pyridazine for the control of foot rot and liver lesions in ruminant animals
US4203968A (en) * 1978-08-18 1980-05-20 Iowa State University Research Foundation, Inc. Combination vaccine for swine dysentery and method of use
IE66015B1 (en) * 1987-09-28 1995-11-29 Beecham Inc TGEV-virus of swine as a dog vaccine

Also Published As

Publication number Publication date
EP0460480B1 (de) 1996-01-24
DE69133172D1 (de) 2003-01-23
CA2043932C (en) 2006-09-12
EP0674905B1 (de) 2002-12-11
CA2043932A1 (en) 1991-12-08
ES2084057T3 (es) 1996-05-01
US6132709A (en) 2000-10-17
IE72181B1 (en) 1997-03-26
EP0460480A2 (de) 1991-12-11
AU644440B2 (en) 1993-12-09
ES2186694T3 (es) 2003-05-16
IE911940A1 (en) 1991-12-18
EP0674905A2 (de) 1995-10-04
EP0674905A3 (de) 1995-12-06
DE69116606T2 (de) 1996-05-30
EP0460480A3 (en) 1992-04-01
NZ238378A (en) 1992-12-23
AU7817791A (en) 1991-12-12
DE69133172T2 (de) 2003-04-30

Similar Documents

Publication Publication Date Title
DE59207750D1 (de) Wegwerfhöschen und Verfahren zur Herstellung desselben
ATA910981A (de) Verfahren zur herstellung kosmetischer und therapeutischer zusammensetzungen
DE69103230D1 (de) 1-Pyridylimidazolderivat und Verfahren zur Herstellung und Anwendung.
ATE108067T1 (de) Impfstoff und verfahren zur herstellung.
DE69115921D1 (de) Verfahren zur behandlung und verwendung von abfallstoffen
DE69129899T2 (de) Verfahren zur Herstellung von D-Alpha-Aminosäuren
DE69011951T2 (de) Verfahren zur Behandlung und Herstellung von Material.
DE69530350D1 (de) Verfahren zur Herstellung von Fluor enthaltende Silikon-Zusammensetzung
DE69118002T2 (de) Verfahren zur Herstellung von 1,1,1-Trifluorchlorethan und 1,1,1,2-Tetrafluorethan
DE69116606T2 (de) Bacterin zur Behandlung von Necrophorum-Krankheiten und Verfahren zur Herstellung
DE59606485D1 (de) Verfahren zur Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
DE69214750T2 (de) Verfahren zur Herstellung von Tribromstyrol und beta-Bromethyltribrombenzol
DE69128406T2 (de) Lateraler MOSFET und Verfahren zur Herstellung
DE59606489D1 (de) Verfahren zur Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
DE69030584D1 (de) Verfahren sowie zusammensetzungen zur behandlung mit vitaminmineral
DE69109243T2 (de) Verfahren zur Herstellung von L-Tryptophan und L-Threonine.
DE69533996D1 (de) Thyristor und Verfahren zur Herstellung
DE59606657D1 (de) Verfahren zur Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
DE69207051T2 (de) Substituierte Acetoxyazetidinonderivate und Verfahren zur Herstellung von 4-Acyloxyazetidinonderivate
DE59606488D1 (de) Verfahren zur Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
DE69128829D1 (de) Feldeffekttransistor und Verfahren zur Herstellung
DE59206187D1 (de) Verfahren zur Herstellung von 4-Alkylsulfonyl-1-alkyl-2-chlorbenzolen und Zwischenprodukte
DE59607034D1 (de) Verfahren zur Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
DE4294717T1 (de) Verfahren zur Herstellung von medizinischen Beuteln
ATE49760T1 (de) 8-haloalkyl-4h-(1)-benzopyran-4-onen und verfahren zur herstellung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee